Innovus Pharmaceuticals, Inc. (INNV)

5.25
5.20 11,094.03
OTC
Prev Close 0.05
Open 3.50
Day Low/High 3.00 / 11.50
52 Wk Low/High 0.04 / 0.18
Volume 1.65K
Exchange OTC
Shares Outstanding 244.84B
Market Cap 11.26M
Div & Yield N.A. (N.A)

Latest News

Innovus Pharma Announces The Approval Of Its Diabasens® Product In Canada Indicated To Relieve Cutaneous Pain Associated With Diabetic Neuropathy

Innovus Pharma Announces The Approval Of Its Diabasens® Product In Canada Indicated To Relieve Cutaneous Pain Associated With Diabetic Neuropathy

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces The Approval Of Its BH™ Testosterone Booster Product In Canada For The Indication To Help To Support Testosterone Levels And Production In Adult Males

Innovus Pharma Announces The Approval Of Its BH™ Testosterone Booster Product In Canada For The Indication To Help To Support Testosterone Levels And Production In Adult Males

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma's Subsidiary, Novalere, Inc., Announces Launch Of Its First Hemp-Derived Cannabidiol Oil-Based Product, MZS Sleeping Aid™ In The United States

Innovus Pharma's Subsidiary, Novalere, Inc., Announces Launch Of Its First Hemp-Derived Cannabidiol Oil-Based Product, MZS Sleeping Aid™ In The United States

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces Regulatory Filings By Its International Distribution Partner, Lavasta Pharma, For ProstaGorx® In Certain Gulf Countries

Innovus Pharma Announces Regulatory Filings By Its International Distribution Partner, Lavasta Pharma, For ProstaGorx® In Certain Gulf Countries

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe...

Innovus Pharma's Product FlutiCare® Ranks #2 Behind Flonase® In Amazon®'s Fluticasone Propionate And Allergy Nasal Spray Categories

Innovus Pharma's Product FlutiCare® Ranks #2 Behind Flonase® In Amazon®'s Fluticasone Propionate And Allergy Nasal Spray Categories

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces The Approval And Launch Of Its OTC Hemorrhoid Xyralid® Suppositories In Canada

Innovus Pharma Announces The Approval And Launch Of Its OTC Hemorrhoid Xyralid® Suppositories In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharmaceuticals Announces $3.17 Million Private Placement

Innovus Pharmaceuticals Announces $3.17 Million Private Placement

Innovus Pharmaceuticals, Inc. (OTCQB: INNV) ("Innovus Pharma" or the "Company"), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and...

Innovus Pharma Announces All Cash Acquisition Of All Of The Assets Of SupplementHunt.com, An E-Commerce Store With Its Proprietary Sales Platform And Marketing Technology

Innovus Pharma Announces All Cash Acquisition Of All Of The Assets Of SupplementHunt.com, An E-Commerce Store With Its Proprietary Sales Platform And Marketing Technology

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces Initiation Of A Clinical Study To Evaluate The Tolerance And The Effect Of Musclin™ On Muscle Health In Adults In The United States

Innovus Pharma Announces Initiation Of A Clinical Study To Evaluate The Tolerance And The Effect Of Musclin™ On Muscle Health In Adults In The United States

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharmaceuticals Acquires Worldwide Rights To Four Products From Boston Topicals, LLC

Innovus Pharmaceuticals Acquires Worldwide Rights To Four Products From Boston Topicals, LLC

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter and consumer care products to improve men's and women's health and...

Innovus Pharma Reports Another New Quarterly Revenue Record Of Approximately $7.4 Million For The Third Quarter 2018 And $19.2 Million For The First Nine Months Of 2018

Innovus Pharma Reports Another New Quarterly Revenue Record Of Approximately $7.4 Million For The Third Quarter 2018 And $19.2 Million For The First Nine Months Of 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and...

Innovus Pharmaceuticals To Release Its Third Quarter 2018 Financial Results On Wednesday, November 14, 2018

Innovus Pharmaceuticals To Release Its Third Quarter 2018 Financial Results On Wednesday, November 14, 2018

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced that the Company will release its September 30, 2018 third quarter financial results on Wednesday, November 14, 2018, after the close of the U.

Innovus Pharmaceuticals Reports Preliminary Q3 2018 Sales Revenue Of $7.0 Million To $7.1 Million

Innovus Pharmaceuticals Reports Preliminary Q3 2018 Sales Revenue Of $7.0 Million To $7.1 Million

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced preliminary third quarter 2018 net revenue is estimated to be between $7.

Innovus Pharma Receives Approval For Medicare Reimbursement For Its GlucoGorx™ Blood Glucose Monitoring System And GlucoGorx™ Blood Glucose Test Strip Products

Innovus Pharma Receives Approval For Medicare Reimbursement For Its GlucoGorx™ Blood Glucose Monitoring System And GlucoGorx™ Blood Glucose Test Strip Products

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces Planned Expansion Into CBD Oil-Based Products Market

Innovus Pharma Announces Planned Expansion Into CBD Oil-Based Products Market

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Receives Approval From Amazon® To Expand Its Amazon® Stores To Japan

Innovus Pharma Receives Approval From Amazon® To Expand Its Amazon® Stores To Japan

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma To Present At H.C. Wainwright 20th Annual Global Investment Conference

Innovus Pharma To Present At H.C. Wainwright 20th Annual Global Investment Conference

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Reports New Quarterly Revenue Record Of $7.3 Million For The Second Quarter 2018 And Expands To Canadian Market

Innovus Pharma Reports New Quarterly Revenue Record Of $7.3 Million For The Second Quarter 2018 And Expands To Canadian Market

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB: INNV), today reported results for the second quarter 2018.

Innovus Pharma Signs Purchase Agreement With "Showcase - The Home Of The Hottest Trends" To Sell The Company's Apeaz® Cream For The Relief Of Arthritis Pain In Its 110 "Showcase" Retail Stores In The United States And Canada

Innovus Pharma Signs Purchase Agreement With "Showcase - The Home Of The Hottest Trends" To Sell The Company's Apeaz® Cream For The Relief Of Arthritis Pain In Its 110 "Showcase" Retail Stores In The United States And Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces Three Regulatory Filings With Health Canada For Its Products: Xyralid® Suppositories, Beyond Human® Testosterone And RecalMax™

Innovus Pharma Announces Three Regulatory Filings With Health Canada For Its Products: Xyralid® Suppositories, Beyond Human® Testosterone And RecalMax™

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharmaceuticals To Release Its Second Quarter 2018 Financial Results On Tuesday, August 14, 2018

Innovus Pharmaceuticals To Release Its Second Quarter 2018 Financial Results On Tuesday, August 14, 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB: INNV) today announced that the Company will release its June 30, 2018 second quarter financial results on Tuesday, August 14, 2018, after the close of the U.

Innovus Pharma Signs Purchase Agreement With CVS Pharmacy, Inc. To Sell Its Product Androferti® To Increase Sperm Quality In Their Newly Established In-Store Men's Clinic

Innovus Pharma Signs Purchase Agreement With CVS Pharmacy, Inc. To Sell Its Product Androferti® To Increase Sperm Quality In Their Newly Established In-Store Men's Clinic

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue Of $6.6 Million To $6.8 Million

Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue Of $6.6 Million To $6.8 Million

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced preliminary second quarter 2018 net revenue is estimated to be between $6.

Innovus Pharma Receives Approval From Amazon® To Expand Its Amazon® Stores To Europe Covering The United Kingdom, France, Germany, Spain And Italy

Innovus Pharma Receives Approval From Amazon® To Expand Its Amazon® Stores To Europe Covering The United Kingdom, France, Germany, Spain And Italy

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces The Launch Of Its Product AllerVarx™ In Canada For Allergic Rhinitis

Innovus Pharma Announces The Launch Of Its Product AllerVarx™ In Canada For Allergic Rhinitis

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces The Approval Of Its Product ProstaGorx™ In Canada For Benign Prostatic Hyperplasia ("BPH")

Innovus Pharma Announces The Approval Of Its Product ProstaGorx™ In Canada For Benign Prostatic Hyperplasia ("BPH")

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma To Exhibit Its FlutiCare® And AllerVarx™ Products At The American Thoracic Society Event In San Diego From Sunday, May 20, 2018 To Tuesday, May 22, 2018

Innovus Pharma To Exhibit Its FlutiCare® And AllerVarx™ Products At The American Thoracic Society Event In San Diego From Sunday, May 20, 2018 To Tuesday, May 22, 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...